Global Seasonal Influenza Vaccines Therapeutics Market Growth (Status and Outlook) 2024-2030

February 2024 | 107 pages | ID: G11FB5978451EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Seasonal Influenza Vaccines Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Seasonal Influenza Vaccines Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Seasonal Influenza Vaccines Therapeutics market. Seasonal Influenza Vaccines Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Seasonal Influenza Vaccines Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Seasonal Influenza Vaccines Therapeutics market.

Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.

The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.

Key Features:

The report on Seasonal Influenza Vaccines Therapeutics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Seasonal Influenza Vaccines Therapeutics market. It may include historical data, market segmentation by Type (e.g., Paediatrics, Adolescence), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Seasonal Influenza Vaccines Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Seasonal Influenza Vaccines Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Seasonal Influenza Vaccines Therapeutics industry. This include advancements in Seasonal Influenza Vaccines Therapeutics technology, Seasonal Influenza Vaccines Therapeutics new entrants, Seasonal Influenza Vaccines Therapeutics new investment, and other innovations that are shaping the future of Seasonal Influenza Vaccines Therapeutics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Seasonal Influenza Vaccines Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Seasonal Influenza Vaccines Therapeutics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Seasonal Influenza Vaccines Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Seasonal Influenza Vaccines Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Seasonal Influenza Vaccines Therapeutics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Seasonal Influenza Vaccines Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Seasonal Influenza Vaccines Therapeutics market.

Market Segmentation:

Seasonal Influenza Vaccines Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Paediatrics
  • Adolescence
  • Adults
  • Elderly
Segmentation by application
  • Hospitals
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GSK
  • Novartis
  • CSL
  • MedImmune
  • Sanofi-Pasteur
  • Solvay
  • Hualan Biological Engineering
  • Sinovac Biotech
  • Changchun Institute of Biological Products Co., Ltd.
  • Shanghai Institute of Biological Products Co., Ltd.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Seasonal Influenza Vaccines Therapeutics Market Size 2019-2030
  2.1.2 Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Seasonal Influenza Vaccines Therapeutics Segment by Type
  2.2.1 Paediatrics
  2.2.2 Adolescence
  2.2.3 Adults
  2.2.4 Elderly
2.3 Seasonal Influenza Vaccines Therapeutics Market Size by Type
  2.3.1 Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Seasonal Influenza Vaccines Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Seasonal Influenza Vaccines Therapeutics Market Size by Application
  2.5.1 Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)

3 SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Players
  3.1.1 Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2019-2024)
  3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Seasonal Influenza Vaccines Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SEASONAL INFLUENZA VACCINES THERAPEUTICS BY REGIONS

4.1 Seasonal Influenza Vaccines Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Seasonal Influenza Vaccines Therapeutics Market Size Growth (2019-2024)
4.3 APAC Seasonal Influenza Vaccines Therapeutics Market Size Growth (2019-2024)
4.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024)
5.2 Americas Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024)
5.3 Americas Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024)
6.2 APAC Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024)
6.3 APAC Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Seasonal Influenza Vaccines Therapeutics by Country (2019-2024)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SEASONAL INFLUENZA VACCINES THERAPEUTICS MARKET FORECAST

10.1 Global Seasonal Influenza Vaccines Therapeutics Forecast by Regions (2025-2030)
  10.1.1 Global Seasonal Influenza Vaccines Therapeutics Forecast by Regions (2025-2030)
  10.1.2 Americas Seasonal Influenza Vaccines Therapeutics Forecast
  10.1.3 APAC Seasonal Influenza Vaccines Therapeutics Forecast
  10.1.4 Europe Seasonal Influenza Vaccines Therapeutics Forecast
  10.1.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Forecast
10.2 Americas Seasonal Influenza Vaccines Therapeutics Forecast by Country (2025-2030)
  10.2.1 United States Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.2.2 Canada Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.2.3 Mexico Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.2.4 Brazil Seasonal Influenza Vaccines Therapeutics Market Forecast
10.3 APAC Seasonal Influenza Vaccines Therapeutics Forecast by Region (2025-2030)
  10.3.1 China Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.3.2 Japan Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.3.3 Korea Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.3.4 Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.3.5 India Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.3.6 Australia Seasonal Influenza Vaccines Therapeutics Market Forecast
10.4 Europe Seasonal Influenza Vaccines Therapeutics Forecast by Country (2025-2030)
  10.4.1 Germany Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.4.2 France Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.4.3 UK Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.4.4 Italy Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.4.5 Russia Seasonal Influenza Vaccines Therapeutics Market Forecast
10.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Forecast by Region (2025-2030)
  10.5.1 Egypt Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.5.2 South Africa Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.5.3 Israel Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.5.4 Turkey Seasonal Influenza Vaccines Therapeutics Market Forecast
  10.5.5 GCC Countries Seasonal Influenza Vaccines Therapeutics Market Forecast
10.6 Global Seasonal Influenza Vaccines Therapeutics Forecast by Type (2025-2030)
10.7 Global Seasonal Influenza Vaccines Therapeutics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK Seasonal Influenza Vaccines Therapeutics Product Offered
  11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Seasonal Influenza Vaccines Therapeutics Product Offered
  11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 CSL
  11.3.1 CSL Company Information
  11.3.2 CSL Seasonal Influenza Vaccines Therapeutics Product Offered
  11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 CSL Main Business Overview
  11.3.5 CSL Latest Developments
11.4 MedImmune
  11.4.1 MedImmune Company Information
  11.4.2 MedImmune Seasonal Influenza Vaccines Therapeutics Product Offered
  11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 MedImmune Main Business Overview
  11.4.5 MedImmune Latest Developments
11.5 Sanofi-Pasteur
  11.5.1 Sanofi-Pasteur Company Information
  11.5.2 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Offered
  11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Sanofi-Pasteur Main Business Overview
  11.5.5 Sanofi-Pasteur Latest Developments
11.6 Solvay
  11.6.1 Solvay Company Information
  11.6.2 Solvay Seasonal Influenza Vaccines Therapeutics Product Offered
  11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Solvay Main Business Overview
  11.6.5 Solvay Latest Developments
11.7 Hualan Biological Engineering
  11.7.1 Hualan Biological Engineering Company Information
  11.7.2 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Offered
  11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Hualan Biological Engineering Main Business Overview
  11.7.5 Hualan Biological Engineering Latest Developments
11.8 Sinovac Biotech
  11.8.1 Sinovac Biotech Company Information
  11.8.2 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Offered
  11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Sinovac Biotech Main Business Overview
  11.8.5 Sinovac Biotech Latest Developments
11.9 Changchun Institute of Biological Products Co., Ltd.
  11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Information
  11.9.2 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Offered
  11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Changchun Institute of Biological Products Co., Ltd. Main Business Overview
  11.9.5 Changchun Institute of Biological Products Co., Ltd. Latest Developments
11.10 Shanghai Institute of Biological Products Co., Ltd.
  11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Information
  11.10.2 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Offered
  11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Shanghai Institute of Biological Products Co., Ltd. Main Business Overview
  11.10.5 Shanghai Institute of Biological Products Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Paediatrics
Table 3. Major Players of Adolescence
Table 4. Major Players of Adults
Table 5. Major Players of Elderly
Table 6. Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Seasonal Influenza Vaccines Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Seasonal Influenza Vaccines Therapeutics Key Players Head office and Products Offered
Table 15. Seasonal Influenza Vaccines Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Seasonal Influenza Vaccines Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Seasonal Influenza Vaccines Therapeutics
Table 47. Key Market Challenges & Risks of Seasonal Influenza Vaccines Therapeutics
Table 48. Key Industry Trends of Seasonal Influenza Vaccines Therapeutics
Table 49. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. GSK Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 54. GSK Seasonal Influenza Vaccines Therapeutics Product Offered
Table 55. GSK Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. GSK Main Business
Table 57. GSK Latest Developments
Table 58. Novartis Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 59. Novartis Seasonal Influenza Vaccines Therapeutics Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Novartis Latest Developments
Table 63. CSL Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 64. CSL Seasonal Influenza Vaccines Therapeutics Product Offered
Table 65. CSL Main Business
Table 66. CSL Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. CSL Latest Developments
Table 68. MedImmune Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 69. MedImmune Seasonal Influenza Vaccines Therapeutics Product Offered
Table 70. MedImmune Main Business
Table 71. MedImmune Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. MedImmune Latest Developments
Table 73. Sanofi-Pasteur Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 74. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Offered
Table 75. Sanofi-Pasteur Main Business
Table 76. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Sanofi-Pasteur Latest Developments
Table 78. Solvay Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 79. Solvay Seasonal Influenza Vaccines Therapeutics Product Offered
Table 80. Solvay Main Business
Table 81. Solvay Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Solvay Latest Developments
Table 83. Hualan Biological Engineering Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 84. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product Offered
Table 85. Hualan Biological Engineering Main Business
Table 86. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Hualan Biological Engineering Latest Developments
Table 88. Sinovac Biotech Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 89. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Offered
Table 90. Sinovac Biotech Main Business
Table 91. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Sinovac Biotech Latest Developments
Table 93. Changchun Institute of Biological Products Co., Ltd. Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 94. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Offered
Table 95. Changchun Institute of Biological Products Co., Ltd. Main Business
Table 96. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Changchun Institute of Biological Products Co., Ltd. Latest Developments
Table 98. Shanghai Institute of Biological Products Co., Ltd. Details, Company Type, Seasonal Influenza Vaccines Therapeutics Area Served and Its Competitors
Table 99. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product Offered
Table 100. Shanghai Institute of Biological Products Co., Ltd. Main Business
Table 101. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Shanghai Institute of Biological Products Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Seasonal Influenza Vaccines Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Seasonal Influenza Vaccines Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Seasonal Influenza Vaccines Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type in 2023
Figure 10. Seasonal Influenza Vaccines Therapeutics in Hospitals
Figure 11. Global Seasonal Influenza Vaccines Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Seasonal Influenza Vaccines Therapeutics in Clinics
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Seasonal Influenza Vaccines Therapeutics in Others
Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Seasonal Influenza Vaccines Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Seasonal Influenza Vaccines Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Seasonal Influenza Vaccines Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Seasonal Influenza Vaccines Therapeutics Value Market Share by Country in 2023
Figure 24. United States Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Seasonal Influenza Vaccines Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Seasonal Influenza Vaccines Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Seasonal Influenza Vaccines Therapeutics Market Size Market Share Forecast by Application (2025-2030)


More Publications